Get started
Author

Ana Maria Alba Ponce

Observed names: A. Ponce, Ana Ponce, Ponce, Ana
ORCID: 0000-0002-2479-4285
Observed ORCID: 0000-0002-2479-4285
OpenAlex ID: A5034812291
Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial
2023 · Jane A. O’Halloran, Emily R. Ko, et al. · JAMA · 74
PDF
The clinical significance of low complement levels in patients with catastrophic antiphospholipid syndrome: A descriptive analysis of 73 patients from the “Catastrophic antiphospholipid syndrome registry”
2022 · Ana Ponce, Ignasi Rodríguez-Pintó, et al. · Lupus · 11
Pulmonary involvement in catastrophic antiphospholipid syndrome: A descriptive analysis from the “CAPS Registry”
2023 · Ana Ponce, Ignasi Rodríguez-Pintó, et al. · Seminars in Arthritis and Rheumatism · 10
Abatacept Pharmacokinetics and Exposure Response in Patients Hospitalized With COVID-19
2024 · Stephen J. Balevic, Daniel K. Benjamin, et al. · JAMA Network Open · 9
PDF
Skin involvement in the catastrophic antiphospholipid syndrome: A review from CAPS registry
2026 · A. Ponce, I. Rodríguez-Pintó, et al. · Lupus · 1
849 - Afectación Pulmonar En El Síndrome Antifosfolípido Catastrófico: Análisis Descriptivo Del “caps Registry”
2023 · Ana Ponce, Ignasi Rodríguez Pintó, et al. · Revista Clínica Española
Works count: 7
Citation count: 105
H-index: 4
I10-index: 3
Year
Topic
Type